Multinational specialty pharmaceutical company
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.
JFK Communications served as Valeant’s PR partner to launch the Acanya Scholarship Program among dermatologists, primary care physicians, pediatricians, patients (students) and parents nationwide.
Acanya is a once–daily topical gel that combines two active ingredients – the antibiotic clindamycin phosphate and the antibacterial/antiinflammatory agent benzoyl peroxide – to treat acne.
JFK provided the following core services:
JFK Communications Inc.
213 Carnegie Center Drive, Suite 7141
Princeton, NJ 08540